Earn more credits by taking our
bundled PCE HOME STUDY activities.

2021 PCE Symposia Expert Insights

2021 PCE Symposia Expert Insights

  • Release Date: October 29, 2021
  • Expiration Date: October 28, 2022
  • Credit Hours Available: 7.00
    Pharmacology Hours for NPs: 7.00

  • Obesity Management Strategies That Can Reap the Benefits of Long-Term Weight Loss
  • Individualizing Management of Overactive Bladder
  • The Landscape of Inflammatory Bowel Disease
  • Improving Outcomes and Reducing Therapeutic Inertia with GLP-1 RA
  • Multiple Sclerosis in Primary Care
  • What’s New in Migraine Management
  • Individualizing Management of Uncontrolled Asthma: New Strategies
2021 PCE Symposia Video Lectures

2021 PCE Symposia Video Lectures

  • Release Date: August 31, 2021
  • Expiration Date: August 30, 2022
  • Credit Hours Available: 5.00
    Pharmacology Hours for NPs: 5.00

  • Reducing the Burden of Uterine Fibroids: Emerging Options for Managing Associated Heavy Menstrual Bleeding
  • Critical Strategies and Approaches to Improve Outcomes in Heart Failure
  • Clinical Advances in the Treatment of Moderate to Severe Atopic Dermatitis: Optimizing Outcomes
  • Managing Influenza in the High-Risk Patient
  • Migraine: Putting New Options Into Clinical Practice
Spring 2021 PCE Oncology

Spring 2021 PCE Oncology

  • Release Date: August 17, 2021
  • Expiration Date: August 16, 2022
  • Credit Hours Available: 11.00
    Pharmacology Hours for NPs: 11.00

  • Targeted Therapies in B-Cell Malignancies: Management of Adverse Events in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Mantle Cell Lymphoma
  • Expanding the Treatment Landscape for Urothelial Cancer
  • Targeting the Clinical Challenges of Metastatic HER2-Positive Breast Cancer With Novel Agents
  • Tackling the Complexities of Relapsed/Refractory Follicular Lymphoma: An Update on Recent Advances
  • Maximizing the Potential of Novel Therapies for Prostate Cancer
  • The Expanding Treatment Landscape for Triple-Negative Breast Cancer
  • Changing the Treatment of Endometrial Cancer: Novel and Emerging Strategies
  • Navigating the Expanding Options for Relapsed/Refractory Multiple Myeloma
  • Optimizing Use of Checkpoint Inhibitors in Non–Small-Cell Lung Cancer
  • Biomarkers, Molecular Analysis, and Choice of Therapy in NSCLC
  • PARP Inhibitor Therapy for Ovarian Cancer: Recent Advances and Existing Challenges
2020 PCE eClinic

2020 PCE eClinic

  • Release Date: March 31, 2021
  • Expiration Date: March 30, 2022
  • Credit Hours Available: 5.00
    Pharmacology Hours for NPs: 5.00

  • Beyond Counting Sheep: New Strategies for Sleep Maintenance Insomnia
  • Reducing the Risk: Advanced Influenza Treatment Options
  • Collaborative Care in the Management of Multiple Sclerosis: Where Does Primary Care Fit?
  • Traversing the Chasm: Overcoming Challenges of Obesity Management in Primary Care
  • Early Identification and Management of Rheumatoid Arthritis: The Critical Role of Primary Care
APP Oncology Bootcamp Powered by PCE

APP Oncology Bootcamp Powered by PCE

  • Release Date: March 20, 2021
  • Expiration Date: March 19, 2022
  • Credit Hours Available: 5.00
    Pharmacology Hours for NPs: 5.00

  • Integrating New Therapies Into the Treatment of Advanced Prostate Cancer
  • New Options for Advanced Renal Cell Carcinoma: Targeted and Immunotherapies
  • Updates in Advanced Pancreatic Cancer: Integrating New Therapies Into Clinical Practice
  • The Evolving Treatment Landscape for Advanced Gastric Cancer: New Data on Novel Treatment Options
  • Applying Recent Advances in Metastatic Colorectal Cancer to Improving Patient Care
Fall 2020 PCE Oncology

Fall 2020 PCE Oncology

  • Release Date: December 16, 2020
  • Expiration Date: December 15, 2021
  • Credit Hours Available: 8.00
    Pharmacology Hours for NPs: 8.00

  • Relapsed/Refractory Multiple Myeloma: Integrating Novel Agents into the Treatment Paradigm
  • The Evolving Landscape of Prostate Cancer Management
  • Managing Patients Treated With CAR T-Cell Therapy
  • Therapeutic Advances in Metastatic HER2-Positive Breast Cancer
  • Immune Checkpoint Inhibitor Therapy: Recognition and Management of Adverse Events
  • Novel Therapies in Advanced Urothelial Cancer: Effective Management of Treatment-Related Toxicities
  • Small Cell Lung Cancer: A Changing Treatment Paradigm
  • Precision Oncology: Identifying and Treating Patients With NSCLC

Development Widget